Literature DB >> 1427874

Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively.

M M Le Beau1, C Ito, P Cogswell, R Espinosa, A A Fernald, A S Baldwin.   

Abstract

The regulation of expression of a variety of genes involved in immune function, inflammation, and cellular growth control, as well as control of expression of certain viruses such as the human immunodeficiency virus (HIV), is dependent on the transcription factor NF-kappa B. In many cells, NF-kappa B is found in the cytoplasm where it is associated with an inhibitor protein known as I kappa B. Recently the genes encoding the p50 and p65 subunits of NF-kappa B, as well as one form of I kappa B/MAD-3 (NFKBI), have been cloned. As part of our goal to determine the chromosomal organization of members of the REL/NFKB family, as well as their inhibitors, we localized the NFKBp50/p105 (NFKB2) and I kappa B/MAD-3 (NFKBI) genes to human chromosome bands 4q24 and 14q13, respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1427874     DOI: 10.1016/s0888-7543(05)80261-7

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  10 in total

1.  Microsatellite genotyping of chromosome 14q13.2-14q13 in the vicinity of proteasomal gene PSMA6 and association with Graves' disease in the Latvian population.

Authors:  Tatjana Sjakste; Jelena Eglite; Arturs Sochnevs; Mara Marga; Valdis Pirags; Yrjö Collan; Nikolajs Sjakste
Journal:  Immunogenetics       Date:  2004-06-17       Impact factor: 2.846

2.  Linkage/association study of a locus modulating total serum IgE on chromosome 14q13-24 in families with asthma.

Authors:  A H Mansur; D T Bishop; S T Holgate; A F Markham; J F J Morrison
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

3.  Genetic polymorphisms of NFκB1 -94 del/ins ATTG, NFκB1A 2758 A>G and SUMO rs237025 G>A in psoriasis.

Authors:  Abdullateef A Alzolibani; Ahmed Settin; Ahmed Ali Ahmed; Hisham Ismail; Noor Elhefni; Ahmad A Al Robaee
Journal:  Int J Health Sci (Qassim)       Date:  2015-01

4.  -449 C>G polymorphism of NFKB1 gene, coding nuclear factor-kappa-B, is associated with the susceptibility to ulcerative colitis.

Authors:  Ranji Hayashi; Tomomitsu Tahara; Tsukasa Yamaaki; Takashi Saito; Kazuhiro Matsunaga; Nobuhiko Hayashi; Atsushi Fukumura; Kazuaki Ozaki; Masakatsu Nakamura; Hisakazu Shiroeda; Mikihiro Tsutsumi; Tomoyuki Shibata; Tomiyasu Arisawa
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

5.  Risk association between the NF-κB1 -94ins/delATTG promoter polymorphism and inflammatory bowel diseases: a meta-analysis.

Authors:  Meilan Liang; Xinyu Xu; Yaoyao Gong; Yurong Tang; Lin Lin
Journal:  Dig Dis Sci       Date:  2012-07-25       Impact factor: 3.199

6.  Polymorphisms in the 3' untranslated region of the I kappa B/MAD-3 (NFKBI) gene located on chromosome 14.

Authors:  D Glavac; M Ravnik-Glavac; S J O'Brien; M Dean
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

7.  Association between NFKB1 -94 insertion/deletion ATTG polymorphism and risk of intracranial aneurysm.

Authors:  Xiutian Sima; Jianguo Xu; Jin Li; Chao You
Journal:  Genet Test Mol Biomarkers       Date:  2013-05-15

8.  NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population.

Authors:  Shunxin Song; Dianke Chen; Jiachun Lu; Jiawei Liao; Yanxin Luo; Zuli Yang; Xinhui Fu; Xinjuan Fan; Yisheng Wei; Lei Yang; Lei Wang; Jianping Wang
Journal:  PLoS One       Date:  2011-06-30       Impact factor: 3.240

9.  Genetic and epigenetic changes in chromosomally stable and unstable progeny of irradiated cells.

Authors:  Janet E Baulch; Umut Aypar; Katrina M Waters; Austin J Yang; William F Morgan
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

10.  Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested case-control study in Shanghai, China.

Authors:  Jing Gao; Hong-Li Xu; Shan Gao; Wei Zhang; Yu-Ting Tan; Nat Rothman; Mark Purdue; Yu-Tang Gao; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  BMJ Open       Date:  2014-02-27       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.